HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

RP3128

calcium release-activated calcium (CRAC) channel modulator; no structure available

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- RP3128: 2

Experts

1.	Viswanadha, Srikant: 2 articles (06/2021 - 02/2016)
2.	Barde, Prajak J: 1 article (06/2021)
3.	Nair, Ajit: 1 article (06/2021)
4.	Vakkalanka, Swaroop V: 1 article (06/2021)
5.	Veeraraghavan, Sridhar: 1 article (06/2021)
6.	Franova, Sona: 1 article (02/2016)
7.	Kocmalova, Michaela: 1 article (02/2016)
8.	Sutovska, Martina: 1 article (02/2016)
9.	Vakkalanka, Swaroop: 1 article (02/2016)

Related Diseases

1.	Asthma (Bronchial Asthma) 02/05/2016 - "This objective of this study was to evaluate the therapeutic potency of a novel CRAC channel inhibitor, RP3128, in experimental models of allergic asthma using guinea pigs. " 02/05/2016 - "Pharmacodynamic evaluation of RP3128, a novel and potent CRAC channel inhibitor in guinea pig models of allergic asthma."
2.	Inflammation (Inflammations) 06/01/2021 - "RP3128 showed nano-molar potency and activity in a range of in vitro and in vivo models of inflammation. " 02/05/2016 - "Data demonstrate the therapeutic potential of RP3128 in respiratory diseases causally associated with allergic inflammation. " 02/05/2016 - "Ovalbumin-induced allergic airway inflammation was determined upon acute and long-term (14 days) oral administration of RP3128. "
3.	Respiratory Tract Diseases (Respiratory Tract Disease) 02/05/2016 - "Data demonstrate the therapeutic potential of RP3128 in respiratory diseases causally associated with allergic inflammation. "

Related Drugs and Biologics

1.	Calcium Release Activated Calcium Channels
2.	Ovalbumin

Related Therapies and Procedures

1.	Oral Administration